nodes	percent_of_prediction	percent_of_DWPC	metapath
Carteolol—CYP2D6—Fingolimod—multiple sclerosis	0.144	0.804	CbGbCtD
Carteolol—Eyelid ptosis—Betamethasone—multiple sclerosis	0.0487	0.0594	CcSEcCtD
Carteolol—Eyelid ptosis—Dexamethasone—multiple sclerosis	0.0487	0.0594	CcSEcCtD
Carteolol—CYP2D6—Dexamethasone—multiple sclerosis	0.035	0.196	CbGbCtD
Carteolol—Atrioventricular block—Fingolimod—multiple sclerosis	0.0247	0.0301	CcSEcCtD
Carteolol—Diabetic—Methylprednisolone—multiple sclerosis	0.0201	0.0245	CcSEcCtD
Carteolol—Diabetic—Dexamethasone—multiple sclerosis	0.0183	0.0223	CcSEcCtD
Carteolol—Diabetic—Betamethasone—multiple sclerosis	0.0183	0.0223	CcSEcCtD
Carteolol—Cerebrovascular accident—Fingolimod—multiple sclerosis	0.0177	0.0216	CcSEcCtD
Carteolol—Conjunctival hyperaemia—Prednisolone—multiple sclerosis	0.0167	0.0203	CcSEcCtD
Carteolol—Conjunctival hyperaemia—Dexamethasone—multiple sclerosis	0.0139	0.0169	CcSEcCtD
Carteolol—Conjunctival hyperaemia—Betamethasone—multiple sclerosis	0.0139	0.0169	CcSEcCtD
Carteolol—Depression—Fingolimod—multiple sclerosis	0.0134	0.0163	CcSEcCtD
Carteolol—Diabetic—Methotrexate—multiple sclerosis	0.0133	0.0162	CcSEcCtD
Carteolol—Sinusitis—Fingolimod—multiple sclerosis	0.0126	0.0153	CcSEcCtD
Carteolol—Bradycardia—Fingolimod—multiple sclerosis	0.0122	0.0149	CcSEcCtD
Carteolol—Keratitis—Prednisolone—multiple sclerosis	0.0113	0.0138	CcSEcCtD
Carteolol—Cerebrovascular accident—Cladribine—multiple sclerosis	0.0101	0.0123	CcSEcCtD
Carteolol—Vision blurred—Fingolimod—multiple sclerosis	0.00987	0.012	CcSEcCtD
Carteolol—Keratitis—Dexamethasone—multiple sclerosis	0.00942	0.0115	CcSEcCtD
Carteolol—Keratitis—Betamethasone—multiple sclerosis	0.00942	0.0115	CcSEcCtD
Carteolol—Palpitations—Fingolimod—multiple sclerosis	0.00926	0.0113	CcSEcCtD
Carteolol—Eye irritation—Prednisolone—multiple sclerosis	0.00858	0.0104	CcSEcCtD
Carteolol—Hypotension—Fingolimod—multiple sclerosis	0.00799	0.00973	CcSEcCtD
Carteolol—Dyspnoea—Fingolimod—multiple sclerosis	0.00762	0.00928	CcSEcCtD
Carteolol—Conjunctivitis—Cladribine—multiple sclerosis	0.00739	0.00899	CcSEcCtD
Carteolol—Cardiac failure congestive—Mitoxantrone—multiple sclerosis	0.00715	0.0087	CcSEcCtD
Carteolol—Asthenia—Fingolimod—multiple sclerosis	0.00613	0.00747	CcSEcCtD
Carteolol—Diabetes mellitus—Prednisolone—multiple sclerosis	0.00611	0.00744	CcSEcCtD
Carteolol—Arrhythmia—Cladribine—multiple sclerosis	0.00609	0.00742	CcSEcCtD
Carteolol—Cardiac failure congestive—Prednisolone—multiple sclerosis	0.00586	0.00714	CcSEcCtD
Carteolol—Dizziness—Fingolimod—multiple sclerosis	0.00565	0.00688	CcSEcCtD
Carteolol—Diabetes mellitus—Triamcinolone—multiple sclerosis	0.00562	0.00685	CcSEcCtD
Carteolol—Visual disturbance—Prednisolone—multiple sclerosis	0.00561	0.00683	CcSEcCtD
Carteolol—Diabetes mellitus—Methylprednisolone—multiple sclerosis	0.00561	0.00683	CcSEcCtD
Carteolol—Cardiac failure congestive—Triamcinolone—multiple sclerosis	0.00539	0.00657	CcSEcCtD
Carteolol—Cardiac failure congestive—Methylprednisolone—multiple sclerosis	0.00538	0.00655	CcSEcCtD
Carteolol—Headache—Fingolimod—multiple sclerosis	0.00536	0.00652	CcSEcCtD
Carteolol—Diabetes mellitus—Dexamethasone—multiple sclerosis	0.0051	0.00621	CcSEcCtD
Carteolol—Diabetes mellitus—Betamethasone—multiple sclerosis	0.0051	0.00621	CcSEcCtD
Carteolol—Arrhythmia—Azathioprine—multiple sclerosis	0.00495	0.00603	CcSEcCtD
Carteolol—Cardiac failure congestive—Betamethasone—multiple sclerosis	0.00489	0.00596	CcSEcCtD
Carteolol—Cardiac failure congestive—Dexamethasone—multiple sclerosis	0.00489	0.00596	CcSEcCtD
Carteolol—Conjunctivitis—Mitoxantrone—multiple sclerosis	0.00485	0.00591	CcSEcCtD
Carteolol—Oedema—Cladribine—multiple sclerosis	0.00485	0.0059	CcSEcCtD
Carteolol—Sinusitis—Mitoxantrone—multiple sclerosis	0.00469	0.00571	CcSEcCtD
Carteolol—Visual disturbance—Betamethasone—multiple sclerosis	0.00468	0.0057	CcSEcCtD
Carteolol—Visual disturbance—Dexamethasone—multiple sclerosis	0.00468	0.0057	CcSEcCtD
Carteolol—Bradycardia—Mitoxantrone—multiple sclerosis	0.00456	0.00556	CcSEcCtD
Carteolol—Respiratory failure—Methotrexate—multiple sclerosis	0.00453	0.00552	CcSEcCtD
Carteolol—Hypotension—Cladribine—multiple sclerosis	0.00453	0.00551	CcSEcCtD
Carteolol—Diabetes mellitus—Prednisone—multiple sclerosis	0.00444	0.00541	CcSEcCtD
Carteolol—Insomnia—Cladribine—multiple sclerosis	0.00438	0.00534	CcSEcCtD
Carteolol—Dyspnoea—Cladribine—multiple sclerosis	0.00432	0.00526	CcSEcCtD
Carteolol—Cardiac failure congestive—Prednisone—multiple sclerosis	0.00426	0.00519	CcSEcCtD
Carteolol—Bronchospasm—Methylprednisolone—multiple sclerosis	0.00415	0.00505	CcSEcCtD
Carteolol—Arrhythmia—Mitoxantrone—multiple sclerosis	0.00401	0.00488	CcSEcCtD
Carteolol—Conjunctivitis—Prednisolone—multiple sclerosis	0.00398	0.00485	CcSEcCtD
Carteolol—Dysgeusia—Mitoxantrone—multiple sclerosis	0.00382	0.00465	CcSEcCtD
Carteolol—Bradycardia—Prednisolone—multiple sclerosis	0.00374	0.00456	CcSEcCtD
Carteolol—Diabetes mellitus—Methotrexate—multiple sclerosis	0.00371	0.00452	CcSEcCtD
Carteolol—Hypotension—Azathioprine—multiple sclerosis	0.00368	0.00448	CcSEcCtD
Carteolol—Vision blurred—Mitoxantrone—multiple sclerosis	0.00368	0.00448	CcSEcCtD
Carteolol—Conjunctivitis—Triamcinolone—multiple sclerosis	0.00366	0.00446	CcSEcCtD
Carteolol—Hypersensitivity—Cladribine—multiple sclerosis	0.00357	0.00435	CcSEcCtD
Carteolol—Visual impairment—Prednisolone—multiple sclerosis	0.00354	0.00432	CcSEcCtD
Carteolol—Asthenia—Cladribine—multiple sclerosis	0.00348	0.00423	CcSEcCtD
Carteolol—Bradycardia—Triamcinolone—multiple sclerosis	0.00344	0.00419	CcSEcCtD
Carteolol—Bradycardia—Methylprednisolone—multiple sclerosis	0.00344	0.00418	CcSEcCtD
Carteolol—Visual disturbance—Methotrexate—multiple sclerosis	0.00341	0.00415	CcSEcCtD
Carteolol—Conjunctivitis—Betamethasone—multiple sclerosis	0.00332	0.00405	CcSEcCtD
Carteolol—Conjunctivitis—Dexamethasone—multiple sclerosis	0.00332	0.00405	CcSEcCtD
Carteolol—Cerebrovascular accident—Methotrexate—multiple sclerosis	0.0033	0.00401	CcSEcCtD
Carteolol—Arrhythmia—Prednisolone—multiple sclerosis	0.00329	0.004	CcSEcCtD
Carteolol—Visual impairment—Methylprednisolone—multiple sclerosis	0.00325	0.00396	CcSEcCtD
Carteolol—Dizziness—Cladribine—multiple sclerosis	0.0032	0.0039	CcSEcCtD
Carteolol—Oedema—Mitoxantrone—multiple sclerosis	0.00319	0.00388	CcSEcCtD
Carteolol—Shock—Mitoxantrone—multiple sclerosis	0.00313	0.00382	CcSEcCtD
Carteolol—Bradycardia—Dexamethasone—multiple sclerosis	0.00312	0.0038	CcSEcCtD
Carteolol—Bradycardia—Betamethasone—multiple sclerosis	0.00312	0.0038	CcSEcCtD
Carteolol—Headache—Cladribine—multiple sclerosis	0.00304	0.0037	CcSEcCtD
Carteolol—Arrhythmia—Triamcinolone—multiple sclerosis	0.00302	0.00368	CcSEcCtD
Carteolol—Vision blurred—Prednisolone—multiple sclerosis	0.00302	0.00367	CcSEcCtD
Carteolol—Arrhythmia—Methylprednisolone—multiple sclerosis	0.00302	0.00367	CcSEcCtD
Carteolol—Hypotension—Mitoxantrone—multiple sclerosis	0.00298	0.00362	CcSEcCtD
Carteolol—Depression—Prednisone—multiple sclerosis	0.00297	0.00362	CcSEcCtD
Carteolol—Visual impairment—Betamethasone—multiple sclerosis	0.00296	0.0036	CcSEcCtD
Carteolol—Visual impairment—Dexamethasone—multiple sclerosis	0.00296	0.0036	CcSEcCtD
Carteolol—Hypersensitivity—Azathioprine—multiple sclerosis	0.0029	0.00354	CcSEcCtD
Carteolol—Dysgeusia—Triamcinolone—multiple sclerosis	0.00288	0.00351	CcSEcCtD
Carteolol—Nausea—Cladribine—multiple sclerosis	0.00288	0.00351	CcSEcCtD
Carteolol—Syncope—Prednisolone—multiple sclerosis	0.00287	0.0035	CcSEcCtD
Carteolol—Dyspnoea—Mitoxantrone—multiple sclerosis	0.00284	0.00346	CcSEcCtD
Carteolol—Loss of consciousness—Prednisolone—multiple sclerosis	0.00281	0.00343	CcSEcCtD
Carteolol—Arrhythmia—Dexamethasone—multiple sclerosis	0.00274	0.00334	CcSEcCtD
Carteolol—Arrhythmia—Betamethasone—multiple sclerosis	0.00274	0.00334	CcSEcCtD
Carteolol—Bradycardia—Prednisone—multiple sclerosis	0.00272	0.00331	CcSEcCtD
Carteolol—Syncope—Triamcinolone—multiple sclerosis	0.00264	0.00322	CcSEcCtD
Carteolol—Syncope—Methylprednisolone—multiple sclerosis	0.00263	0.00321	CcSEcCtD
Carteolol—Oedema—Prednisolone—multiple sclerosis	0.00261	0.00318	CcSEcCtD
Carteolol—Dizziness—Azathioprine—multiple sclerosis	0.00261	0.00317	CcSEcCtD
Carteolol—Loss of consciousness—Triamcinolone—multiple sclerosis	0.00259	0.00315	CcSEcCtD
Carteolol—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.00258	0.00314	CcSEcCtD
Carteolol—Shock—Prednisolone—multiple sclerosis	0.00257	0.00313	CcSEcCtD
Carteolol—Depression—Methotrexate—multiple sclerosis	0.00248	0.00302	CcSEcCtD
Carteolol—Headache—Azathioprine—multiple sclerosis	0.00247	0.00301	CcSEcCtD
Carteolol—Conjunctivitis—Methotrexate—multiple sclerosis	0.00242	0.00295	CcSEcCtD
Carteolol—Oedema—Triamcinolone—multiple sclerosis	0.0024	0.00293	CcSEcCtD
Carteolol—Syncope—Betamethasone—multiple sclerosis	0.0024	0.00292	CcSEcCtD
Carteolol—Syncope—Dexamethasone—multiple sclerosis	0.0024	0.00292	CcSEcCtD
Carteolol—Arrhythmia—Prednisone—multiple sclerosis	0.00239	0.00291	CcSEcCtD
Carteolol—Shock—Triamcinolone—multiple sclerosis	0.00236	0.00288	CcSEcCtD
Carteolol—Insomnia—Prednisolone—multiple sclerosis	0.00236	0.00288	CcSEcCtD
Carteolol—Shock—Methylprednisolone—multiple sclerosis	0.00236	0.00287	CcSEcCtD
Carteolol—Loss of consciousness—Betamethasone—multiple sclerosis	0.00235	0.00286	CcSEcCtD
Carteolol—Loss of consciousness—Dexamethasone—multiple sclerosis	0.00235	0.00286	CcSEcCtD
Carteolol—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.00235	0.00286	CcSEcCtD
Carteolol—Nausea—Azathioprine—multiple sclerosis	0.00234	0.00285	CcSEcCtD
Carteolol—Asthenia—Mitoxantrone—multiple sclerosis	0.00229	0.00278	CcSEcCtD
Carteolol—Hypotension—Methylprednisolone—multiple sclerosis	0.00224	0.00273	CcSEcCtD
Carteolol—Vision blurred—Prednisone—multiple sclerosis	0.00219	0.00267	CcSEcCtD
Carteolol—Oedema—Betamethasone—multiple sclerosis	0.00218	0.00266	CcSEcCtD
Carteolol—Oedema—Dexamethasone—multiple sclerosis	0.00218	0.00266	CcSEcCtD
Carteolol—Insomnia—Triamcinolone—multiple sclerosis	0.00217	0.00265	CcSEcCtD
Carteolol—Insomnia—Methylprednisolone—multiple sclerosis	0.00217	0.00264	CcSEcCtD
Carteolol—Visual impairment—Methotrexate—multiple sclerosis	0.00215	0.00262	CcSEcCtD
Carteolol—Shock—Betamethasone—multiple sclerosis	0.00215	0.00261	CcSEcCtD
Carteolol—Shock—Dexamethasone—multiple sclerosis	0.00215	0.00261	CcSEcCtD
Carteolol—Dyspnoea—Triamcinolone—multiple sclerosis	0.00214	0.00261	CcSEcCtD
Carteolol—Syncope—Prednisone—multiple sclerosis	0.00209	0.00254	CcSEcCtD
Carteolol—Loss of consciousness—Prednisone—multiple sclerosis	0.00205	0.00249	CcSEcCtD
Carteolol—Hypotension—Dexamethasone—multiple sclerosis	0.00204	0.00248	CcSEcCtD
Carteolol—Hypotension—Betamethasone—multiple sclerosis	0.00204	0.00248	CcSEcCtD
Carteolol—Headache—Mitoxantrone—multiple sclerosis	0.002	0.00243	CcSEcCtD
Carteolol—Insomnia—Dexamethasone—multiple sclerosis	0.00197	0.0024	CcSEcCtD
Carteolol—Insomnia—Betamethasone—multiple sclerosis	0.00197	0.0024	CcSEcCtD
Carteolol—Hypersensitivity—Prednisolone—multiple sclerosis	0.00193	0.00234	CcSEcCtD
Carteolol—Dysgeusia—Methotrexate—multiple sclerosis	0.0019	0.00232	CcSEcCtD
Carteolol—Oedema—Prednisone—multiple sclerosis	0.0019	0.00231	CcSEcCtD
Carteolol—Nausea—Mitoxantrone—multiple sclerosis	0.00189	0.0023	CcSEcCtD
Carteolol—Shock—Prednisone—multiple sclerosis	0.00187	0.00228	CcSEcCtD
Carteolol—Vision blurred—Methotrexate—multiple sclerosis	0.00183	0.00223	CcSEcCtD
Carteolol—Hypersensitivity—Triamcinolone—multiple sclerosis	0.00177	0.00216	CcSEcCtD
Carteolol—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.00177	0.00215	CcSEcCtD
Carteolol—Dizziness—Prednisolone—multiple sclerosis	0.00173	0.0021	CcSEcCtD
Carteolol—Asthenia—Triamcinolone—multiple sclerosis	0.00172	0.0021	CcSEcCtD
Carteolol—Asthenia—Methylprednisolone—multiple sclerosis	0.00172	0.00209	CcSEcCtD
Carteolol—Insomnia—Prednisone—multiple sclerosis	0.00172	0.00209	CcSEcCtD
Carteolol—Headache—Prednisolone—multiple sclerosis	0.00164	0.00199	CcSEcCtD
Carteolol—Dizziness—Triamcinolone—multiple sclerosis	0.00159	0.00194	CcSEcCtD
Carteolol—Dizziness—Methylprednisolone—multiple sclerosis	0.00159	0.00193	CcSEcCtD
Carteolol—Asthenia—Betamethasone—multiple sclerosis	0.00156	0.00191	CcSEcCtD
Carteolol—Asthenia—Dexamethasone—multiple sclerosis	0.00156	0.00191	CcSEcCtD
Carteolol—Nausea—Prednisolone—multiple sclerosis	0.00155	0.00189	CcSEcCtD
Carteolol—Headache—Triamcinolone—multiple sclerosis	0.00151	0.00183	CcSEcCtD
Carteolol—Headache—Methylprednisolone—multiple sclerosis	0.0015	0.00183	CcSEcCtD
Carteolol—Hypotension—Methotrexate—multiple sclerosis	0.00148	0.00181	CcSEcCtD
Carteolol—Dizziness—Dexamethasone—multiple sclerosis	0.00144	0.00176	CcSEcCtD
Carteolol—Dizziness—Betamethasone—multiple sclerosis	0.00144	0.00176	CcSEcCtD
Carteolol—Insomnia—Methotrexate—multiple sclerosis	0.00144	0.00175	CcSEcCtD
Carteolol—Nausea—Triamcinolone—multiple sclerosis	0.00143	0.00174	CcSEcCtD
Carteolol—Nausea—Methylprednisolone—multiple sclerosis	0.00142	0.00173	CcSEcCtD
Carteolol—Dyspnoea—Methotrexate—multiple sclerosis	0.00141	0.00172	CcSEcCtD
Carteolol—Hypersensitivity—Prednisone—multiple sclerosis	0.0014	0.0017	CcSEcCtD
Carteolol—Headache—Dexamethasone—multiple sclerosis	0.00137	0.00166	CcSEcCtD
Carteolol—Headache—Betamethasone—multiple sclerosis	0.00137	0.00166	CcSEcCtD
Carteolol—Asthenia—Prednisone—multiple sclerosis	0.00136	0.00166	CcSEcCtD
Carteolol—Nausea—Dexamethasone—multiple sclerosis	0.0013	0.00158	CcSEcCtD
Carteolol—Nausea—Betamethasone—multiple sclerosis	0.0013	0.00158	CcSEcCtD
Carteolol—Dizziness—Prednisone—multiple sclerosis	0.00126	0.00153	CcSEcCtD
Carteolol—Headache—Prednisone—multiple sclerosis	0.00119	0.00145	CcSEcCtD
Carteolol—Hypersensitivity—Methotrexate—multiple sclerosis	0.00117	0.00142	CcSEcCtD
Carteolol—Asthenia—Methotrexate—multiple sclerosis	0.00114	0.00139	CcSEcCtD
Carteolol—Nausea—Prednisone—multiple sclerosis	0.00113	0.00137	CcSEcCtD
Carteolol—Dizziness—Methotrexate—multiple sclerosis	0.00105	0.00128	CcSEcCtD
Carteolol—Headache—Methotrexate—multiple sclerosis	0.000994	0.00121	CcSEcCtD
Carteolol—Nausea—Methotrexate—multiple sclerosis	0.000943	0.00115	CcSEcCtD
